English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/77292
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

LOXL2 in epithelial cell plasticity and tumor progression

AuthorsCano, Amparo ; Santamaría, Patricia G.; Moreno-Bueno, Gema
Issue Date2012
PublisherFuture Medicine
CitationFuture Oncology 8(9): 1095-1108 (2012)
AbstractSeveral members of the lysyl oxidase family have recently emerged as important regulators of tumor progression. Among them, LOXL2 has been shown to be involved in tumor progression and metastasis of several tumor types, including breast carcinomas. Secreted LOXL2 participates in the remodeling of the extracellular matrix of the tumor microenvironment, in a similar fashion to prototypical lysyl oxidase. In addition, new intracellular functions of LOXL2 have been described, such as its involvement in the regulation of the epithelial-to-mesenchymal transition, epithelial cell polarity and differentiation mediated by transcriptional repression mechanisms. Importantly, intracellular (perinuclear) expression of LOXL2 is associated with poor prognosis and distant metastasis of specific tumor types, such as larynx squamous cell carcinoma and basal breast carcinomas. These recent findings open new avenues for the therapeutic utility of LOXL2. © 2012 Future Medicine Ltd.
URIhttp://hdl.handle.net/10261/77292
DOI10.2217/fon.12.105
Identifiersdoi: 10.2217/fon.12.105
issn: 1479-6694
e-issn: 1744-8301
Appears in Collections:(IIBM) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.